####################
# Output from PRIME (v2.0)
# Alleles: A2601
# Affinity predictions: MixMHCpred (/Users/annieborch/Documents/programs/MixMHCpred-master/MixMHCpred)
# Input file: /Users/annieborch/Documents/IMPROVE/IMPROVE_git/IMPROVE_tool/results/predictions/PRIME/tempPept.txt
#
# PRIME is freely available for academic users.
# Private companies should contact Nadette Bulgin (nbulgin@lcr.org) at the Ludwig Institute for Cancer Research Ltd for commercial licenses.
# To cite PRIME2.0, please refer to:
# Gfeller et al. Predictions of immunogenicity reveal potent SARS-Cov-2 CD8 T-cell epitopes, BioRxiv (2022).
####################
Peptide	%Rank_bestAllele	Score_bestAllele	%RankBinding_bestAllele	BestAllele	%Rank_A2601	Score_A2601	%RankBinding_A2601
SYSFHSPSHY	10.638	0.006243	5.932	A2601	10.638	0.006243	5.932
RVILADIHY	0.653	0.068094	1.489	A2601	0.653	0.068094	1.489
DTCMVVGFF	0.427	0.087485	0.423	A2601	0.427	0.087485	0.423
DEVFDFWDTM	4.944	0.013852	11.237	A2601	4.944	0.013852	11.237
